The purpose of this study was to compare and characterize histopathologically the virulence of two bacterial strains in a naturally susceptible animal host. One of the strains Pseudomonas aeruginosa ATCC 19660, routinely used in this laboratory, produces endopthalmitis and phthisis bulbi in C57BL/6 mice within 3–4 weeks. The other bacterial strain, a clinical isolate from a 70-year-old patient with Pseudomonas corneal infection was found to be less virulent in the patient and thus was examined for virulence in the susceptible mouse model. The strain also proved to be less virulent in the normally susceptible mouse when compared with ATCC 19660. In general, when comparing the histopathological response of the mice to the two bacterial strains, it was found that in contrast to ATCC 19660, (1) fewer polymorphonuclear neutrophils migrated into the cornea at 24–72 h, (2) endothelial and epithelial necrosis was delayed, (3) few free bacteria were observed in the cornea and (4) animals recovered corneal clarity by 21–25 days following infection.

Keywords:
Cornea, Bacterial infection, Mice, Microscopy
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.